N. Skinner

发表

Convergent antibody responses associated with broad neutralization of hepatitis C virus and clearance of infection

S. Ray, J. Crowe, S. Yegnasubramanian, 2021, medRxiv.

Broadly neutralizing antibodies against hepatitis C virus: location, location, location.

J. Bailey, N. Skinner, 2020, Journal of hepatology.

IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function

Jamie B. Spangler, S. Zeger, O. Laeyendecker, 2022, JCI insight.

Decreased Activated CD4+ T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4+ T Cell Recovery.

R. El-Diwany, S. Ray, S. Wheelan, 2021, Viral immunology.

Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1

E. Seaquist, G. Nelsestuen, M. Wroblewski, 2015, Diabetes Therapy.

Durable SARS-CoV-2 B cell immunity after mild or severe disease.

S. Ray, S. Klein, M. Betenbaugh, 2021, The Journal of clinical investigation.

Durable SARS-CoV-2 B cell immunity after mild or severe disease

S. Ray, S. Klein, M. Betenbaugh, 2020, medRxiv.

The Time is Now: A Call for Renewed Support of Infectious Diseases Physician-Scientist Trainees in the Era of Coronavirus Disease 2019

J. Queen, J. Howard-Anderson, M. Melia, 2021, The Journal of infectious diseases.

Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation

G. Tsokos, V. Kyttaris, K. Maeda, 2018, Proceedings of the National Academy of Sciences.

Convergent antibody responses are associated with broad neutralization of hepatitis C virus

K. Schuebel, S. Ray, J. Crowe, 2023, Frontiers in Immunology.

B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection

S. Ray, P. Bjorkman, J. Crowe, 2022, PLoS pathogens.

Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance.

A. Flyak, J. Bailey, N. Skinner, 2024, Immunity.